Compare Abeona Therapeutics Inc (ABEO) vs Omnicom Group Inc. (OMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Omnicom Group Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Omnicom Group Inc. trades at $85.74 (market cap $23.58B). The key difference: Omnicom Group Inc. is far larger — about 56× Abeona Therapeutics Inc's market cap, and Omnicom Group Inc. pays a 3.72% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | OMC | |
|---|---|---|
Market Cap | $421.19M | $23.58B |
Sector | Health | Media |
52-Week High | $7.45 | $86.22 |
52-Week Low | $4.17 | $67.27 |
Enterprise Value | $276.10M | $31.66B |
Dividend Yield | — | 3.72% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →
